A detailed history of Atlantic Union Bankshares Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 382 shares of IBRX stock, worth $794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
382
Previous 764 50.0%
Holding current value
$794
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$2.24 - $3.01 $855 - $1,149
-382 Reduced 50.0%
382 $0
Q2 2025

Aug 06, 2025

BUY
$1.89 - $3.44 $1,443 - $2,628
764 New
764 $2,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $833M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Atlantic Union Bankshares Corp Portfolio

Follow Atlantic Union Bankshares Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.